Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (5985)	12/7/1998 10:19:00 AM
From: Dauntless	Respond to of 7041

Nancy & Thread - Trust the facts!! Regarding the use of "news" by Zonagen to prop up their stock price, if you go to their web site, www.zonagen.com you will see that they have issued 15 communications since March. Five reported filings and/or approvals of regulatory submissions. Four announced quarterly & annual SEC filings, two have announced patent approvals, and two have announced $5 million milestone payments. That's 13 of the 15 - not much room for hyping, huh? All of these press releases easily meet the requirements for public company reporting. In case some members of the thread are TOO BUSY to check out the facts, here's the list from the web site. News Releases: 12/07/98 Zonagen Initiates Phase I Clinical Trials of Vasofem for the Treatment of Female Sexual Dysfunction 11/19/98 Michael T. Redman Joins Zonagen as Vice President of Business Development 11/16/98 Zonagen Reports Third Quarter Results 09/24/98 Zonagen Earns $5 Million Milestone for Vasomax 09/08/98 Zonagen Announces Marketing Application Filed in U.K. for Vasomax 08/10/98 Zonagen Reports Second Quarter Results 07/23/98 Zonagen Receives Notice of Allowance for ImmuMax Adjuvant System Patent 07/15/98 Zonagen Files NDA for Vasomax 06/11/98 Zonagen to Receive $5 Million Milestone Payment From Schering-Plough 06/02/98 Zonagen Reports Phase III Results With Vasomax; Data Presented at the American Urological Association Annual Meeting 05/29/98 Vasomax Approved in Mexico 05/15/98 Zonagen Reports First Quarter Results 03/31/98 Zonagen Reports Fourth Quarter and 1997 Year End Results 03/25/98 Zonagen Receives Lowrey Patent for Vasomax 03/19/98 Zonagen Announces Product Registration Filed in Mexico for Vasomax